01 · The Goal

Regenerate the reproductive tissue the body cannot replace on its own

The goal is to regenerate reproductive tissue — regrowing reproductive tissues damaged by disease or treatment. It is, in the end, about a person — whether they spend years managing loss, or get to live fully again.

02 · Why It Matters

Reproductive health shapes whether and when people can have children, and the reproductive system ages early and is easily damaged by disease and cancer treatment. Regenerating reproductive tissue, restoring fertility, and slowing reproductive aging would expand real reproductive choice and protect long-term hormonal health. This is about real choice — the freedom to decide whether and when to have a family, protected from disease and time.

03 · What We’re Trying to Achieve

We are building the capability to regrow reproductive tissue: from stem cells, engineered tissue, and the biology that drives true regeneration. The aim is a clear path from what already works in the clinic today to the regenerative science advancing toward tomorrow — honestly staged at every step.

04 · How It Works

How it works

Stem-cell and tissue therapies Demonstrated in research

Lab-grown cells and tissue regrow structure in animal studies and early trials.

Engineered tissue Frontier

Building functional replacement tissue in the lab is an advancing frontier.

Regeneration in the body Frontier

Coaxing the body to regenerate the tissue itself is early-stage laboratory science.

Engineered tissue & integration Clinical

Building functional, blood-supplied replacement tissue — and getting it to integrate and last — is advancing from the lab toward the clinic.

05 · Who’s Building It

Cited as evidence the capability is real — not as partners or endorsers.

Government & programs

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD, NIH) · NIH reproductive-biology programs. These public programs fund the foundational research that shows the capability is real.

Universities & institutes

Academic reproductive-medicine and fertility-regeneration research centers. Academic laboratories carry that science from discovery toward the clinic.

Enabling science base

gamete & gonadal biology · reproductive stem cells · fertility preservation · reproductive endocrinology. — the established disciplines this capability is built upon.

06 · Technologies

The technologies: reproductive tissue and cell therapies, fertility-preservation and restoration, ovarian and gonadal regeneration biology, and reproductive-endocrine medicine.

07 · Breakthroughs

Cell therapy Demonstrated

Cells regrow structure in research.

Engineered tissue Frontier

Replacement tissue is advancing in the lab.

In-body regeneration Frontier

Regenerating in place is early-stage.

From bench toward bedside Clinical trials

The first regenerative therapies have entered human trials — the transition from demonstrated regrowth toward real treatment.

08 · Remaining Challenges

The honest challenges: regrowing cells is increasingly possible; building functional, integrated, durable tissue in people is the largely frontier challenge. Regrowing cells is increasingly within reach; building functional, blood-supplied, lasting tissue inside a living person is the harder, largely frontier challenge — and the one the field is racing to solve. Every line here is tagged for its real stage, so what is demonstrated is never confused with what is deployed.

09 · Mature Capability

The future, fully built

Reproductive tissue that the body cannot replace is regenerated — regrown, engineered, and restored — so loss becomes repairable. — and the honest staging on this page shows just how much of that future is already real, and how much is still being built.

Honest boundary: each item is tagged for where it stands — demonstrated, clinical, or frontier. The science is real, funded, and accelerating. AI supports human clinicians; it never replaces them.
10 · Evidence Vault

The proof, for this capability

Cited as evidence the capability is real, not as partners or endorsers.

Cell therapy

Cells regrow structure in research and early trials. Stage: Demonstrated.

Engineered tissue

Replacement tissue is advancing. Stage: Frontier.

In-body regeneration

Regenerating in place is early-stage. Stage: Frontier.

Honest framing

Real organizations are cited as evidence the capability is real — not as partners or endorsers. Full functional regeneration in people is frontier and not claimed as routine.

Where it stands

Each line above is tagged for its stage — demonstrated, clinical, or frontier — so the page shows exactly how far the real science has come, and how far is left.

Help build this future

Every signature grows the movement to make reproductive-tissue regeneration real — and free at the point of need.

Paid for by Michael Floyd for President.

Scroll to Top